Vaxcyte
Cynthia (Bihui) Hao is an accomplished financial executive with extensive experience in technical accounting, revenue recognition, and SEC reporting. Currently serving as VP, Controller at Vaxcyte since September 2024, Cynthia previously held the role of VP, Global Controller at New Relic and spent several years at Palo Alto Networks as VP of Technical Accounting, Technical Revenue, SEC Reporting, and Accounting Policy. Prior positions include Director of Technical Accounting and Accounting Policies at Juniper Networks and Senior Manager at PricewaterhouseCoopers. Cynthia began their career as an Auditor at Arthur Andersen. Educational achievements include a Stanford Executive Program certification, an MBA from the University of Wisconsin-Madison, and a Bachelor of Business Administration from Peking University.
This person is not in any teams
Vaxcyte
2 followers
Vaxcyte, formerly known as SutroVax, is a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.